Omada Health CEO exercises options, sells shares
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Omada Health, Inc. chief executive officer Sean P. Duffy exercised stock options covering a total of 21,570 shares of common stock at exercise prices of $8.28 and $9.18 on August 7 and 10, 2026, and sold 21,570 shares, including a weighted-average sale at $24.8075, pursuant to a 10b5-1 trading plan adopted on March 13, 2026. The filing also reports 851,659 shares of common stock held indirectly in family trusts for his family members, with beneficial ownership disclaimed except for his pecuniary interest.
Insider Trade Summary 10b5-1
Exercise and Sale: 21,570 shares ($317K approx. pre-tax spread)
Exercise and Sale
9 txns
Insider
Duffy Sean P.
Role
Chief Executive Officer
Sold
21,570 shs ($510K)
Approx. gross sale proceeds
$510K
Approx. exercise cost
$193K
Approx. pre-tax spread
$317K
Share of Position Sold
5.0%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F1, F4 | 12,942 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 12,942 | $9.18 | $119K |
| Sale | Common Stock F1, F2 | 12,942 | $24.8075 | $321K |
| Exercise | Stock Option (Right to Buy) F1, F4 | 5,545 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F1, F4 | 3,083 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 5,545 | $8.28 | $46K |
| Exercise | Common Stock F1 | 3,083 | $9.18 | $28K |
| Sale | Common Stock F1 | 4,314 | $20.90 | $90K |
| Sale | Common Stock F1 | 4,314 | $22.80 | $98K |
| Holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 627,840 contracts (Direct);
Common Stock — 411,861 shares (Direct);
Common Stock — 851,659 shares (Indirect, See footnote)
Holdings Before and After:
Stock Option (Right to Buy), 649,410 to 627,840 contracts (Direct);
Common Stock, 411,861 to 411,861 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (4)
- F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
- F2. This transaction was executed in multiple trades at prices ranging from $24.70 to $25.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. Held in family trusts for the benefit of the Reporting Person's family members. The Reporting Person disclaims beneficial ownership of the shares held by the family trusts except to the extent of his pecuniary interest therein.
- F4. 100% of the shares subject to the option are fully vested and exercisable.
Key Figures
Options exercised: 21,570 shares
Shares sold: 21,570 shares
Exercise prices: $8.28 and $9.18 per share
+3 more
6 metrics
Options exercised
21,570 shares
Total underlying common shares from options exercised on August 7 and 10, 2026
Shares sold
21,570 shares
Total Omada Health common shares sold in reported transactions
Exercise prices
$8.28 and $9.18 per share
Exercise or conversion prices for Stock Option (Right to Buy) positions
Weighted-average sale price
$24.8075 per share
Weighted-average price for 12,942 shares sold on August 10, 2026
Indirectly held shares
851,659 shares
Common stock held in family trusts for Reporting Person’s family members
10b5-1 plan adoption date
March 13, 2026
Date of trading plan covering the reported transactions
Key Terms
10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, pecuniary interest, +1 more
5 terms
10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A 10b5-1 trading plan is a pre-arranged strategy that allows company insiders to buy or sell company stock at set times, regardless of their current knowledge about the company's situation. It acts like a scheduled appointment for trading, helping prevent the appearance of impropriety or insider trading. This plan provides a way for insiders to sell or buy shares in a controlled, transparent manner, offering reassurance to investors about fair trading practices.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy) with underlying common stock"
weighted average price financial
"This transaction was executed in multiple trades... The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
pecuniary interest financial
"disclaims beneficial ownership of the shares... except to the extent of his pecuniary interest therein"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of the shares held by the family trusts"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions did Omada Health (OMDA) CEO Sean P. Duffy report on this Form 4?
Sean P. Duffy reported exercising stock options for 21,570 shares of Omada Health common stock and then selling 21,570 shares. The activity occurred on August 7 and 10, 2026, and involved both derivative and non-derivative securities.
Were Sean P. Duffy’s Omada Health (OMDA) trades made under a 10b5-1 plan?
Yes. A footnote states the transactions were made pursuant to a 10b5-1 trading plan adopted by Sean P. Duffy on March 13, 2026. Such plans prearrange trades, limiting the informational value of their timing.
What stock options did Sean P. Duffy exercise in Omada Health (OMDA)?
He exercised fully vested Stock Options (Right to Buy) for 21,570 underlying shares at exercise prices of $8.28 and $9.18, with option expiration dates in 2031 and 2032, converting them into Omada Health common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
